U.S. Hemoglobin A1c Monitoring Markets

Frost & Sullivan, April 2003

Education Campaigns on Seriousness of Diabetes to Increase Usage of HbA1c Monitors

Dissemination of information on the graveness of diabetes is expected to do away with the popular perception of the disease as an easily controlled, low-risk condition, and consequently, boost demand for glucose and HbA1c monitoring devices. Physicians also have to be targeted by the promoters since most diabetics are treated by generalists, who might not always be up-to-date on the features of HbA1c monitors. This way, patients will benefit from improved health awareness as well as conditions and physicians from the realization that HbA1c testing has few drawbacks.

This Frost & Sullivan research examines the U.S. HbA1c Monitoring Market. It offers revenue forecasts by market segment, covers key drivers and restraints, and provides strategic recommendations to overcome market challenges.

Inactive Lifestyle Leads to Tremendous Increase in the Number of Diabetics, thereby Driving Sales of Monitors

Refined foods, passive entertainment, and sedentary lifestyles have led to a phenomenal rise in the incidence of obesity, which, in turn, has resulted in a manifold increase in the number of Type 2 diabetics. Although the diabetic population is expected to grow by 150 percent by 2009 due to imprudent lifestyles, the ones already diagnosed with the disease have started monitoring their conditions judiciously and this translates into increased need for complementary HbA1c monitoring.

Type 2 diabetics who wish to follow strict diet regimens to control their condition can be targeted by vendors of monitoring devices that could collaborate with publishers of niche diabetic cookbooks. Providing vouchers with such books can not only raise consumers' awareness of the disease, but perhaps even encourage them to investigate further and eventually use the voucher to purchase HbA1c tests, says the analyst.

Managed Care Organizations Offer Sizeable Reimbursements to Encourage Testing

Managed care organizations (MCOs) that provide health insurance hope to spur interest in, and compliance with testing by providing free tests through payments or waivers on patients' co-pays. MCOs are willing to reimburse all four annual HbA1c tests recommended by the American Diabetes Association, while Medicare allows ten free tests per year. The growing attractiveness of the market has impelled private payors to compete in the like by declaring that the number of tests for which reimbursements can be claimed will have no ceiling.

As more corroborative evidence on the long-term benefits of consistent testing streams in, reimbursement rates and the number of insurance companies that cover HbA1c tests are expected to increase concurrently. As managed care, disease management groups, and industry participants band together to feasibly enable proactive diabetes management, the HbA1c market is expected to experience renewed growth, mainly through increased volumes in sales of tests, asserts the analyst.

1Executive Summary
A.Executive Summary

1Executive Summary

2Total Market
A.Market Overview

1Introduction

2Market Engineering Analysis

3Research Methodology
B.Competitive Structure and Revenue Forecasts

1Drivers

2Restraints

3Competitive Structure

4Revenue Forecasts
C.Challenges and Strategies

1Challenges

2Strategies
D.Market Engineering Awards

1Product Differentiation Innovation Award

2Business Development Strategy Award

3Product Line Strategy Award

3HbA1c Point of Care and Self-Monitoring Market
A.Market Overview

1Introduction

2Trends
B.Demand Product and Pricing Analysis

1Demand Analysis

2Product Analysis

3Pricing Analysis
C.Revenue Forecasts and Market Share Analysis

1Revenue Forecasts

2Market Share Analysis

4HbA1c Laboratory Testing Market
A.Market Overview

1Introduction

2Trends
B.Demand Product and Pricing Analysis

1Demand Analysis

2Product Analysis

3Pricing Analysis
C.Revenue Forecasts and Market Share Analysis

1Revenue Forecasts

2Market Share Analysis

Customers who bought this item also bought

• Hemoglobin A1c Monitoring - Global Strategic Business Report
• Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis
• Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape
• U.S. Point-of-care Testing Markets
• European Diabetes Diagnostics Market
• Diabetes Diagnostics - Global Strategic Business Report
• Bydureon FDA Approval: Physician Opinion
• Hot Topics in Type 2 Diabetes: Physician Perceptions of Insulin - Physician survey provides insights into insulin usage and needs
• Living with Diabetes in the UK
• Living with Diabetes in Germany